Oramed Insulin Capsule: Phase IIb started

Oramed began a double-blind, placebo-controlled U.S. Phase IIb trial to evaluate 2 doses of ORMD-0801 given at bedtime for 28 days in about 180 Type II diabetics who are inadequately controlled with d...